Category Archives: Neuroscience

Neuroscience

Study Reveals Link between Diversity in Daily Experiences and Sense of Well-Being | Neuroscience, Psychology – Sci-News.com

New and diverse daily experiences are linked to enhanced happiness, according to a study published in the journal Nature Neuroscience.

Heller et al reveal a previously unknown connection between our daily physical environments and sense of well-being. Image credit: Frank MoreLight.

Our results suggest that people feel happier when they have more variety in their daily routines: when they go to novel places and have a wider array of experiences, said New York Universitys Dr. Catherine Hartley, lead co-author of the study.

The opposite is also likely true: positive feelings may drive people to seek out these rewarding experiences more frequently.

In the study, Dr. Hartley and colleagues investigated the following question: is diversity in humans daily experiences associated with more positive emotional states?

To do so, the researchers conducted GPS tracking of participants in New York and Miami for three to four months, asking subjects by text message to report about their positive and negative emotional state during this period.

The results showed that on days when people had more variability in their physical location visiting more locations in a day and spending proportionately equitable time across these locations they reported feeling more positive: happy, excited, strong, relaxed, and/or attentive.

The scientists then sought to determine if this link between exploration and positive emotion had a connection to brain activity.

To do this, about half of the subjects returned to a laboratory and underwent MRI scans.

The MRI results showed that people for whom this effect was the strongest those whose exposure to diverse experiences was more strongly associated with positive feeling (affect) exhibited greater correlation between brain activity in the hippocampus and the striatum.

These are brain regions that are associated, respectively, with the processing of novelty and reward beneficial or subjectively positive experiences.

These results suggest a reciprocal link between the novel and diverse experiences we have during our daily exploration of our physical environments and our subjective sense of well-being, Dr. Hartley said.

Collectively, these findings show the beneficial consequences of environmental enrichment across species, demonstrating a connection between real-world exposure to fresh and varied experiences and increases in positive emotions, said lead co-author Dr. Aaron Heller, a researcher at the University of Miami.

_____

A.S. Heller et al. Association between real-world experiential diversity and positive affect relates to hippocampal-striatal functional connectivity. Nat Neurosci, published online May 18, 2020; doi: 10.1038/s41593-020-0636-4

Read the original post:
Study Reveals Link between Diversity in Daily Experiences and Sense of Well-Being | Neuroscience, Psychology - Sci-News.com

Neuroscience

Student Research Awards Named by Center for Research on Families – UMass News and Media Relations

The Center for Research on Families (CRF) has announced the recipients of this year's Student Research Awards.

CRF is committed to supporting students engaged in family research, with student researchers addressing family challenges such as malnutrition in older adults, womens health in remote regions of the world, health effects of breastfeeding, socioemotional development of the multiracial children, how brain structures affect memory and how young childrens ability to understand language influences brain development.

The awards program recognizes outstanding student research on issues related to families.

Dissertation Award Recipients:

Bi-sek Hsaiao, School of Public Health and Health Sciences, nutrition

Sarah McCormick, College of Natural Sciences, psychological and brain science

Merika Sanders, College of Natural Sciences, psychological and brain science

Methodology Scholarship Recipient:

Christina Rowley, College of Natural Sciences, clinical psychology

Travel Award Recipients:

Youngjoon Bae, College of Social and Behavioral Sciences, sociology

Melise Edwards, College of Natural Sciences, neuroscience and behavior

Olivia Laramie, School of Behavioral Sciences, public policy

Learn more about the awardees and their researchhere.

Original post:
Student Research Awards Named by Center for Research on Families - UMass News and Media Relations

Neuroscience

Neuroscience Market Necessity And Demand 2020 to 2026 – Galus Australis

The global Neuroscience Market research report thoroughly explains each and every aspect related to the Neuroscience Market, which facilitates the reports reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Neuroscience Market. A pathway of development is offered by the market to the several connected networks of businesses under it, which include different firms, industries, organizations, vendors, distributors, and local manufacturers too. All the key Neuroscience Market players compete with each other by offering better products and services at a reasonable price in order to grab significant share at the regional and global level market.

Get Summary Of this Report : https://www.coherentmarketinsights.com/market-insight/neuroscience-market-2487

The report includes the latest coverage of the impact of COVID-19 on the Neuroscience Market. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.

The report incorporates an estimated impact of strict standards and regulations set by the government over the market in the upcoming years. The market report also comprises exhaustive research done using several analytical tools such as SWOT analysis to identify the market growth pattern.

Major Players Are:Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Inc., Newport Corporation, Plexon Inc., Noldus Information Technology, Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

Regions & Countries Mentioned In The Neuroscience Market Report:

We Do Offer Sample of this report. Kindly go through the follow information in order to access the report.

** Note This report sample includes:

Receive Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2487

Key Highlights of the Table of Contents:

Role of Neuroscience Market Report:

The global Neuroscience Market has been appearing as one of the most profit-making businesses in the globe. The market has been exhibiting considerable growth figures led by raw material affluence, increasing population, expanding regions, rapid elevating demand, and advanced technologies. The report is likely to be performed vigorously in the upcoming phase, analysts predicted after studying the market at a minute level.

Various analytical tools such as SWOT, Feasibility analysis, Porters Five Forces analysis, Value Chain analysis, and Capacity utilization analysis are implemented while evaluating the Neuroscience Market which certainly helps a reader to get a deeper perception of the market and its participants. Additionally, it covers a cardinal evaluation of market history, patterns, changing dynamics, market and manufacturing trends, demand and supply activities, and technological development.

**Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.

Buy This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2487

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact Us

Mr. ShahCoherent Market Insights, 1001 4th Ave, #3200, Seattle, WA 98154Phone: US +12067016702 / UK +4402081334027Email: sales@coherentmarketinsights.comVisit Blog: http://bit.ly/Rajkumar123

Link:
Neuroscience Market Necessity And Demand 2020 to 2026 - Galus Australis

Neuroscience

UTeach Dallas Students Show They are Class Acts, Secure K-12 Jobs – University of Texas at Dallas

When the COVID-19 pandemic closed K-12 schools in North Texas, three University of Texas at Dallas seniors in the UTeach Dallas program took the initiative to help their mentor teachers in area school districts transition to online learning. Now each has been hired at the same school where they performed their student teaching.

Tommy Fabyan

Tommy Fabyan, who earned a bachelors degree in interdisciplinary studies and a mathematics certificate, will teach math at Trent Middle School in the Frisco Independent School District. Neuroscience senior Aaly Hussain has landed a job teaching science at Skyline High School in Dallas ISD, while David Le, who graduated with a Bachelor of Science degree in biology, will be a science teacher at North Garland High School in Garland ISD.

Students in the UTeach Dallas program earn undergraduate degrees, primarily in STEM fields science, technology, engineering and math concurrently with teacher training and certification.The program is housed in the Department of Science/Mathematics Education in the School of Natural Sciences and Mathematics.

Fabyan, Hussain and Le are among the 26 UTeach Dallas students who have graduated or will graduate this year by August. Four more students have been hired as teachers at Dallas, Houston and Amarillo schools. Two more have completed the Master of Arts in Teaching program and will go on to share their expertise with area students.

UTeach Dallas is the gift that keeps giving to the University, because our graduates are teaching STEM subjects to younger students in the area, many of whom will go on to enroll at UTDallas. Its a long-term investment that pays off.

Katie Donaldson, assistant director of UTeach Dallas

Many UTeach Dallas graduates receive multiple job offers because of their subject expertise and experience in the classroom, said Katie Donaldson, assistant director of UTeach Dallas and master teacher.

Were getting calls daily from employers. Our students have a deep, rich content knowledge coming in to professional teaching. We put them in schools their first semester, helping teachers with fourth- or fifth-grade science or math. Before they ever start their student teaching, they have had 18 to 20 hours in the classroom, Donaldson said.

All of them were student teaching when COVID-19 hit, she added. We told them to jump in and help their teachers wherever they could.

Fabyan had several challenges as he was completing his student teaching. His close-knit family had come to the U.S. from Ghana when he was 13. When his mother also a teacher had to undergo medical treatment last fall, Fabyan dropped out of student teaching to help care for her. After she stabilized, he returned to teaching this spring.

As the COVID-19 pandemic prompted teachers to transition completely to online learning for middle school math classes, Fabyan took charge of digital instruction for kids who did not respond particularly well to lectures. He set up Zoom tutorial sessions, videos and math games to target the areas where students needed help.

To get them even an inch closer to the aha! moment was amazing, Fabyan said.

He credited his mentor teacher for helping him overcome obstacles and even land a job at the school.

Being able to finally cross that finish line in my student teaching was really great. My mentor teacher has been my biggest cheerleader from the day I met her. She told me to invite the principal to watch me teach, so when it came to hiring someone, they already knew what I was capable of in the classroom, Fabyan said.

Aaly Hussain

At Skyline High School, Hussain was able to combine her love of the sciences and teaching, working with two different mentors to teach anatomy, physiology and pre-Advanced Placement chemistry. She decided to pursue teaching after working as a tutor in high school, where students told her she explained things nicely.

By the time COVID-19 hit, Hussain had already been using the online platform Google Classroom to upload assignments and videos that allowed students to do their projects online and receive feedback quickly.

It was perfect, Hussain said of the transition to online learning. I think its easier for my generation because we grew up with it. I had a good exchange with my mentors and set up Google pages for classes and internships.

Hussain, who is also a pre-med student, hopes to go to medical school and become a faculty member after gaining more teaching experience. The teaching aspect of it is what intrigues me, Hussain said.

David Le

Le, who will teach either chemistry or physics at North Garland High School this fall, also helped his mentors quickly formulate plans for online learning using interactive platforms to upload PowerPoint presentations, worksheets and videos with questions for students to answer.

When he learned he was going to be hired at the school, Le was thrilled and a little surprised. I slapped myself to see if I was awake, he said.

A first-generation college student, Le credited UTeach Dallas for stimulating his interest in STEM education. Being placed in a classroom early in his college career helped him realize that he enjoyed class preparation and interacting with students.

After being in the classroom, I was in love. UTeach pushed me when I needed it most. The energy and passion of the master teachers was out of this world. It was contagious, Le said.

Since 2008, UTeach Dallas has graduated almost 200 students with science or mathematics certification. All faculty instructors are award-winning master teachers with years of expertise.

UTeach Dallas is the gift that keeps giving to the University, because our graduates are teaching STEM subjects to younger students in the area, many of whom will go on to enroll at UTDallas. Its a long-term investment that pays off, Donaldson said.

More here:
UTeach Dallas Students Show They are Class Acts, Secure K-12 Jobs - University of Texas at Dallas

Neuroscience

What near-death experiences can tell scientists about how the brain works – Boing Boing

Floating out of your body and looking down on it. The story of your life flashing by before your eyes. Seeing a bright light at the end of a dark tunnel. These are just two of the most common experiences that people report after a near-death experience (NDE). For some people, NDEs are a transformative spiritual or mystical experience. But what's the source of the phenomena? That's a question that fascinates Dr. Christof Koch is president and chief scientist of the Allen Institute for Brain Science who studies the neuroscience of consciousness. In Scientific American, Koch surveys the science of near-death experiences and what they can tell us about how our brains work under extreme duress. From Scientific American:

Modern death requires irreversible loss of brain function. When the brain is starved of blood flow (ischemia) and oxygen (anoxia), the patient faints in a fraction of a minute and his or her electroencephalogram, or EEG, becomes isoelectricin other words, flat. This implies that large-scale, spatially distributed electrical activity within the cortex, the outermost layer of the brain, has broken down. Like a town that loses power one neighborhood at a time, local regions of the brain go offline one after another. The mind, whose substrate is whichever neurons remain capable of generating electrical activity, does what it always does: it tells a story shaped by the persons experience, memory and cultural expectations.

Given these power outages, this experience may produce the rather strange and idiosyncratic stories that make up the corpus of NDE reports. To the person undergoing it, the NDE is as real as anything the mind produces during normal waking. When the entire brain has shut down because of complete power loss, the mind is extinguished, along with consciousness. If and when oxygen and blood flow are restored, the brain boots up, and the narrative flow of experience resumes.[...]

Why the mind should experience the struggle to sustain its operations in the face of loss of blood flow and oxygen as positive and blissful rather than as panic-inducing remains mysterious. It is intriguing, though, that the outer limit of the spectrum of human experience encompasses other occasions in which reduced oxygen causes pleasurable feelings of jauntiness, light-headedness and heightened arousaldeepwater diving, high-altitude climbing, flying, the choking or fainting game, and sexual asphyxiation.

"What Near-Death Experiences Reveal about the Brain" (SciAm)

image: detail of "Ascent of the Blessed" by Hieronymus Bosch

Repeating the word fuck actually can reduce your experience of pain, according to a new study by Keele University researchers. The psychologists ran an experiment in which subjects underwent a cold pressor test, a common method to pain threshold and tolerance by immersing your hand in freezing cold water for a minute. (See above video []

I enjoy the fun science stunts on ScienceBobs YouTube Channel.

The Lancet says Trumps letter contains factually incorrect details.

Weve all been cooped up in the house for way too long. Even though were all trying to be more health-conscious these days, the confinement is likely doing a number on both the physical and psychological health of millions. Young or old, male or female, its time for many to take some proactive steps toward []

At some point in the future, global communications networks will likely reach one standardized protocol that everyone uses. If you look back over the past few decades, theres a decent chance that when the story of digital networking is finally settled once and for all, its Cisco and Cisco-based systems that the globe will be []

Weve all grown accustomed to the new world order. And until we can go out and experience the world again like we used to, well settle for the next best thing: bringing the world to our door. And if ever there was a time for wine (and lots of it), its now. So even if []

Originally posted here:
What near-death experiences can tell scientists about how the brain works - Boing Boing

Neuroscience

Ironshore to Present Posters at the 2020 Neuroscience Education Institute Virtual Scientific Poster Session – Yahoo Finance

Ironshore Pharmaceuticals Inc. ("Ironshore"), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in the commercialization of novel treatments for Attention-Deficit/Hyperactivity Disorder ("ADHD"), today announced it is presenting two posters featuring new analyses of its novel delayed-release and extended-release methylphenidate formulation. These analyses demonstrate that the uniphasic drug delivery system and site of absorption produce a gradual absorption and protracted elimination phase resulting in attenuated peak drug concentration levels across the dosing range and may lead to a dose-dependent duration of effect. The posters are available for download at the Virtual Scientific Poster Session of the Neuroscience Education Institute ("NEI"). This initiative was coordinated in response to the COVID-19 pandemic and is designed to fill the void in the presentation and dissemination of emerging science historically presented during live meetings. The posters will be accessible to NEIs 65,700 members and subscribers at http://nei.global/vsp.

The two poster presentations are:

Model-Based Approach to Establish Predicted Clinical Response of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) for ADHD TreatmentRoberto Gomeni, PhD, Marina Komolova, PhD; Bev Incledon, PhD; Stephen V. Faraone, PhDhttps://www.neiglobal.com/VSP/NEIVSPDetail/tabid/562/args/7/Default.aspx

Site-Specific Colonic Absorption for an Optimized Pharmacokinetic Profile of DR/ER-MPH for the Treatment of ADHDFeng Zhang, PhD; Norberto J. DeSousa, MA; F. Randy Sallee, MD, PhD; David Lickrish; Bev Incledon, PhDhttps://www.neiglobal.com/VSP/NEIVSPDetail/tabid/562/args/6/Default.aspx

The posters will enable NEIs stakeholders to learn more about JORNAY PM (methylphenidate HCl) extended-release capsules CII, which was approved in August 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of ADHD in patients 6 years and older.

"Ironshore is proud to participate in NEIs innovative new forum to present data that are relevant to psychiatrists, psychiatric nurse practitioners, and other mental health care professionals," said Dr. Randy Sallee, Ironshores Chief Medical Officer. "We look forward to sharing new data related to the unique absorption profile of JORNAY PM facilitated by the DELEXIS delayed-release, extended-release, drug delivery technology as well as an evaluation of the medicines pharmacokinetic profile, after single 20mg and 100mg doses, in relation to that of other FDA-approved stimulant medications."

Dr. Bev Incledon, EVP, Research & Development for Ironshore Pharmaceuticals & Development, Inc. added, "Head-to-head studies assessing safety and efficacy of Jornay PM and other stimulants have not been conducted and Jornay PM is not substitutable with other methylphenidate products on a milligram per milligram basis. In this analysis, a 100-mg dose of JORNAY PM produces a maximum serum methylphenidate concentration that is either equal to or lower than that of 54mg and 60mg of other methylphenidate products. While this may surprise some healthcare professionals, this result is directly attributable to the site of absorption for Jornay PM, the colon, which has vastly different absorption qualities relative to the stomach and upper intestine. Although the Cmax was proportionately lower than expected, the absorption window was significantly longer. Together, this resulted in 74% bioavailability relative to a Ritalin IR comparator."

JORNAY PM is the first and only stimulant medication that is dosed in the evening and has demonstrated improved ADHD symptom control in the early morning, throughout the day and during the evening time period in two pivotal Phase 3 trials.

WARNING: ABUSE AND DEPENDENCE

See full prescribing information for complete boxed warning.

See additional important safety information below.

JORNAY PM is the first product to leverage the novel DELEXIS delayed-release and extended-release drug delivery technology that contains two functional film coatings. The first layer delays the initial release of drug for up to 10 hours while the second layer helps to control the rate of release of the active pharmaceutical ingredient from the time the patient awakens the next morning, throughout the day and into the evening.

About ADHDADHD is among the most common childhood psychiatric conditions with behavioral symptoms fluctuating throughout the day. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors, or be overly active. Many home-based difficulties for children and adolescents with ADHD occur during the early morning routine (i.e., before the school day begins).

Story continues

About JORNAY PMDeveloped by Ironshore Pharmaceuticals & Development, Inc., JORNAY PM is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people six years of age and older. JORNAY PM may help increase attention and decrease impulsiveness and hyperactivity in people six years of age and older with ADHD. It is not known if JORNAY PM is safe and effective in children under six years of age.

JORNAY PM is dosed once daily in the evening and should be initiated at 8:00 p.m. Timing of administration of JORNAY PM may be adjusted between 6:30 p.m. and 9:30 p.m. to optimize the tolerability and the efficacy the next morning and throughout the day. The recommended starting dose for patients 6 years and older is 20 mg once daily in the evening. Dosage may be titrated weekly in increments of 20 mg per day up to maximum daily dose of 100 mg. The mean optimized dose required to improve symptoms from the time the patient wakes up, throughout the day and into the evening in children 6-12 years old was 67 mg in Study 1 and 68.1 mg in Study 2. The relative bioavailability of JORNAY PM (given once a day) compared to the same daily dose of a methylphenidate immediate-release oral product (given 3 times a day) in adults is approximately 74%. JORNAY PM is primarily absorbed in the colon which may contribute to the reduced bioavailability of the drug. JORNAY PM is not interchangeable on a milligram-per-milligram basis with other methylphenidate formulations.

Please see additional dosing information in the full prescribing information for JORNAY PM at http://ironshorepharma.com/labeling.pdf.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCECNS stimulants, including JORNAY PM, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.

CONTRAINDICATIONS

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

PREGNANCY AND LACTATION

Please visit http://ironshorepharma.com/labeling.pdf for additional important safety information and the Full Prescribing Information, including Boxed Warning, for JORNAY PM.

About Ironshore Pharmaceuticals Inc.Ironshore Pharmaceuticals Inc. commercializes innovative, patient-centric treatment options to improve the lives of patients and caregivers. Based in North Carolina, Ironshore Pharmaceuticals Inc. is responsible for the sales, marketing and distribution of pharmaceutical products within the US. Ironshore Pharmaceuticals Inc. is a wholly owned subsidiary of Highland Therapeutics Inc. based in Toronto, Canada.

About Ironshore Pharmaceuticals & Development, Inc.Ironshore Pharmaceuticals & Development, Inc., based in Grand Cayman, develops novel therapeutics by leveraging its proprietary drug-delivery technology, DELEXIS. Ironshore Pharmaceuticals & Development, Inc. is a wholly owned subsidiary of Highland Therapeutics Inc. based in Toronto, Canada.

Forward-Looking StatementsThis press release contains forward-looking information, which reflects Ironshores current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Ironshores control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. These forward-looking statements are made as of the date of this press release and, except as expressly required by applicable law, Ironshore assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005104/en/

Contacts

Lora GrassilliKovak-Likly Communications(203) 762-8833lgrassilli@klcpr.com

Read the original post:
Ironshore to Present Posters at the 2020 Neuroscience Education Institute Virtual Scientific Poster Session - Yahoo Finance

Neuroscience

Aaron, Autry, Shinohara Honored with the Binswanger Prize for Excellence in Teaching – Wesleyan Connection

Every spring, Wesleyan recognizes outstanding faculty with three Binswanger Prizes for Excellence in Teaching.

This years recipients include Gloster Aaron, associate professor of biology, Robyn Autry, associate professor and chair of sociology, and Keiji Shinohara, artist-in-residence.

Made possible by gifts from the family of the late Frank G. Binswanger Sr., Hon. 85, these prizes underscore Wesleyans commitment to its scholar-teachers, who are responsible for the Universitys distinctive approach to liberal arts education.

Recommendations are solicited from alumni of the last 10 graduating classes, as well as current juniors, seniors, and graduate students. Recipients are chosen by a selection committee of faculty and members of the Alumni Association Executive Committee.

The Binswanger awards will be presented in person on a future occasion. The recipients and their bios are below:

Gloster Aaron

Gloster Aaron, associate professor of biology, joined the Wesleyan faculty in January 2006. He holds a BA in Neuroscience from Oberlin College and a PhD in Neuroscience from the University of Pennsylvania. Aarons lab pursues research projects related to the understanding, prevention, and treatment of epilepsy, using optical and electrophysiological methods of measuring neuronal activity. His research has included testing whether stem cell-derived, GABAergic neurons that are transplanted into adult brains can functionally integrate into hippocampal circuits and provide seizure-preventing inhibition. In related projects, he is also studying how newly-born neurons develop and are incorporated in adult brain circuits. With regards to epilepsy, he studies the dynamics of seizures that are functionally connected by the corpus callosum, the main white matter tract connecting the two cerebral cortices of the brain. This project seeks to explain the role GABAergic inhibition plays in the propagation of these seizures between hemispheres.

At Wesleyan, Aaron teaches courses in Behavioral Neurobiology; Waves, Brains, and Music; and Neurophysiology, among others. He is the director of WesMaSS, an academic program designed to support students from traditionally underrepresented groups as they pursue studies in mathematics and science.

Robin Autry

Robyn Autry, associate professor and chair of sociology, has been a member of Wesleyans faculty since 2010. She is a writer and critical sociologist with broad interests in racial identity, memory, and blackness. Her academic writing on commemorative practices around racial violence in the United States and South Africa has appeared in several journals, includingVisual StudiesandTheory & Society.Her public writing has appeared inTheAtlanticandBlack Perspectives. She is the author ofDesegregating the Past: The Public Life of Memory in the United States and South Africa (2017).Her second book,Selfishly Black, is currently under review.

She is the recipient of the Andrew W. Mellon Public Humanities Fellowship at the University of Toronto for the 202021 academic year. At Wesleyan, she teaches a range of courses including Social Analysis; Race, Fantasy, Fetish; and The Hair Class.

Keiji Shinohara

Keiji Shinohara, artist-in-residence, has taught at Wesleyan since 1995. Born and raised in Osaka, Japan, he studied as an apprentice to the renowned Keiichiro Uesugi in Kyoto for a decade before becoming a Master Printmaker. Shinoharas natural abstractions are printed on rice paper with water-based inks from woodblocks in the Ukiyo-e style.

Shinohara has been a visiting artist at over 100 venues, and has received grants from the Japan Foundation and the National Endowment for the Arts. His work is featured in many public collections, including the Fine Arts Museum of San Francisco, the Cleveland Museum of Art, the Milwaukee Art Museum, the Fogg Art Museum at Harvard University, and the Library of Congress. He has given lectures at the Los Angeles County Museum of Art, Museum of Fine Arts Boston, Metropolitan Museum of Art, and the Smithsonian Institution, among others. At Wesleyan, he teaches courses including Intro to Sumi-e Painting, Monotype Printmaking, and Alternative Printmaking: Beginning Japanese Woodblock Technique.

Read the original:
Aaron, Autry, Shinohara Honored with the Binswanger Prize for Excellence in Teaching - Wesleyan Connection

Neuroscience

PDE Inhibitors Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| 3w Market News Reports – 3rd Watch News

The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global PDE Inhibitors market. It informs readers about key trends and opportunities in the global PDE Inhibitors market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global PDE Inhibitors market.

Key companies operating in the global PDE Inhibitors market include Hanmi Science Holding, Boehringer Ingelheim, Takeda Pharmaceuticals, AstraZeneca, Bayer, Celgene, Eli Lilly, Pfizer, BioCrea, Dart NeuroScience, Carinopharm, CTC Bio, FORUM Pharmaceuticals, Intra-Cellular Therapies, Omeros Corporation, Medimetriks Pharmaceuticals, NuSirt Biopharma, Palobiopharma, Roivant Sciences, Sagene Pharmaceuticals, Tetra Discovery Partners, Tritech Biopharm, Otsuka, Chiesi Farmaceutici, Verona Pharma, etc.

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1762608/covid-19-impact-on-pde-inhibitors-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global PDE Inhibitors market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global PDE Inhibitors Market Segment By Type:

,PDE5,PDE4,Viagra,Cialis,Levitra,Others

Global PDE Inhibitors Market Segment By Application:

,Genitourinary,Cardiovascular Diseases,Dermatological Disorders,Respiratory Diseases,Schizophrenia,AlzheimerS Disease,HuntingtonS Disease,Others

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global PDE Inhibitors market.

Key companies operating in the global PDE Inhibitors market include Hanmi Science Holding, Boehringer Ingelheim, Takeda Pharmaceuticals, AstraZeneca, Bayer, Celgene, Eli Lilly, Pfizer, BioCrea, Dart NeuroScience, Carinopharm, CTC Bio, FORUM Pharmaceuticals, Intra-Cellular Therapies, Omeros Corporation, Medimetriks Pharmaceuticals, NuSirt Biopharma, Palobiopharma, Roivant Sciences, Sagene Pharmaceuticals, Tetra Discovery Partners, Tritech Biopharm, Otsuka, Chiesi Farmaceutici, Verona Pharma, etc.

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1762608/covid-19-impact-on-pde-inhibitors-market

TOC

1.1 Research Scope1.2 Market Segmentation1.3 Research Objectives1.4 Research Methodology1.4.1 Research Process1.4.2 Data Triangulation1.4.3 Research Approach1.4.4 Base Year1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections1.5.2 Covid-19 Impact: Commodity Prices Indices1.5.3 Covid-19 Impact: Global Major Government Policy1.6 The Covid-19 Impact on PDE Inhibitors Industry1.7 COVID-19 Impact: PDE Inhibitors Market Trends 2 Global PDE Inhibitors Quarterly Market Size Analysis2.1 PDE Inhibitors Business Impact Assessment COVID-192.1.1 Global PDE Inhibitors Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.1.2 Global PDE Inhibitors Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-20262.2 Global PDE Inhibitors Quarterly Market Size 2020-20212.3 COVID-19-Driven Market Dynamics and Factor Analysis2.3.1 Drivers2.3.2 Restraints2.3.3 Opportunities2.3.4 Challenges 3 Quarterly Competitive Assessment, 20203.1 Global PDE Inhibitors Quarterly Market Size by Manufacturers, 2019 VS 20203.2 Global PDE Inhibitors Factory Price by Manufacturers3.3 Location of Key Manufacturers PDE Inhibitors Manufacturing Factories and Area Served3.4 Date of Key Manufacturers Enter into PDE Inhibitors Market3.5 Key Manufacturers PDE Inhibitors Product Offered3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on PDE Inhibitors Segments, By Type4.1 Introduction1.4.1 PDE51.4.2 PDE41.4.3 Viagra1.4.4 Cialis1.4.5 Levitra1.4.6 Others4.2 By Type, Global PDE Inhibitors Market Size, 2019-20214.2.1 By Type, Global PDE Inhibitors Market Size by Type, 2020-20214.2.2 By Type, Global PDE Inhibitors Price, 2020-2021 5 Impact of Covid-19 on PDE Inhibitors Segments, By Application5.1 Overview5.5.1 Genitourinary5.5.2 Cardiovascular Diseases5.5.3 Dermatological Disorders5.5.4 Respiratory Diseases5.5.5 Schizophrenia5.5.6 AlzheimerS Disease5.5.7 HuntingtonS Disease5.5.8 Others5.2 By Application, Global PDE Inhibitors Market Size, 2019-20215.2.1 By Application, Global PDE Inhibitors Market Size by Application, 2019-20215.2.2 By Application, Global PDE Inhibitors Price, 2020-2021 6 Geographic Analysis6.1 Introduction6.2 North America6.2.1 Macroeconomic Indicators of US6.2.2 US6.2.3 Canada6.3 Europe6.3.1 Macroeconomic Indicators of Europe6.3.2 Germany6.3.3 France6.3.4 UK6.3.5 Italy6.4 Asia-Pacific6.4.1 Macroeconomic Indicators of Asia-Pacific6.4.2 China6.4.3 Japan6.4.4 South Korea6.4.5 India6.4.6 ASEAN6.5 Rest of World6.5.1 Latin America6.5.2 Middle East and Africa 7 Company Profiles7.1 Hanmi Science Holding7.1.1 Hanmi Science Holding Business Overview7.1.2 Hanmi Science Holding PDE Inhibitors Quarterly Production and Revenue, 20207.1.3 Hanmi Science Holding PDE Inhibitors Product Introduction7.1.4 Hanmi Science Holding Response to COVID-19 and Related Developments7.2 Boehringer Ingelheim7.2.1 Boehringer Ingelheim Business Overview7.2.2 Boehringer Ingelheim PDE Inhibitors Quarterly Production and Revenue, 20207.2.3 Boehringer Ingelheim PDE Inhibitors Product Introduction7.2.4 Boehringer Ingelheim Response to COVID-19 and Related Developments7.3 Takeda Pharmaceuticals7.3.1 Takeda Pharmaceuticals Business Overview7.3.2 Takeda Pharmaceuticals PDE Inhibitors Quarterly Production and Revenue, 20207.3.3 Takeda Pharmaceuticals PDE Inhibitors Product Introduction7.3.4 Takeda Pharmaceuticals Response to COVID-19 and Related Developments7.4 AstraZeneca7.4.1 AstraZeneca Business Overview7.4.2 AstraZeneca PDE Inhibitors Quarterly Production and Revenue, 20207.4.3 AstraZeneca PDE Inhibitors Product Introduction7.4.4 AstraZeneca Response to COVID-19 and Related Developments7.5 Bayer7.5.1 Bayer Business Overview7.5.2 Bayer PDE Inhibitors Quarterly Production and Revenue, 20207.5.3 Bayer PDE Inhibitors Product Introduction7.5.4 Bayer Response to COVID-19 and Related Developments7.6 Celgene7.6.1 Celgene Business Overview7.6.2 Celgene PDE Inhibitors Quarterly Production and Revenue, 20207.6.3 Celgene PDE Inhibitors Product Introduction7.6.4 Celgene Response to COVID-19 and Related Developments7.7 Eli Lilly7.7.1 Eli Lilly Business Overview7.7.2 Eli Lilly PDE Inhibitors Quarterly Production and Revenue, 20207.7.3 Eli Lilly PDE Inhibitors Product Introduction7.7.4 Eli Lilly Response to COVID-19 and Related Developments7.8 Pfizer7.8.1 Pfizer Business Overview7.8.2 Pfizer PDE Inhibitors Quarterly Production and Revenue, 20207.8.3 Pfizer PDE Inhibitors Product Introduction7.8.4 Pfizer Response to COVID-19 and Related Developments7.9 BioCrea7.9.1 BioCrea Business Overview7.9.2 BioCrea PDE Inhibitors Quarterly Production and Revenue, 20207.9.3 BioCrea PDE Inhibitors Product Introduction7.9.4 BioCrea Response to COVID-19 and Related Developments7.10 Dart NeuroScience7.10.1 Dart NeuroScience Business Overview7.10.2 Dart NeuroScience PDE Inhibitors Quarterly Production and Revenue, 20207.10.3 Dart NeuroScience PDE Inhibitors Product Introduction7.10.4 Dart NeuroScience Response to COVID-19 and Related Developments7.11 Carinopharm7.11.1 Carinopharm Business Overview7.11.2 Carinopharm PDE Inhibitors Quarterly Production and Revenue, 20207.11.3 Carinopharm PDE Inhibitors Product Introduction7.11.4 Carinopharm Response to COVID-19 and Related Developments7.12 CTC Bio7.12.1 CTC Bio Business Overview7.12.2 CTC Bio PDE Inhibitors Quarterly Production and Revenue, 20207.12.3 CTC Bio PDE Inhibitors Product Introduction7.12.4 CTC Bio Response to COVID-19 and Related Developments7.13 FORUM Pharmaceuticals7.13.1 FORUM Pharmaceuticals Business Overview7.13.2 FORUM Pharmaceuticals PDE Inhibitors Quarterly Production and Revenue, 20207.13.3 FORUM Pharmaceuticals PDE Inhibitors Product Introduction7.13.4 FORUM Pharmaceuticals Response to COVID-19 and Related Developments7.14 Intra-Cellular Therapies7.14.1 Intra-Cellular Therapies Business Overview7.14.2 Intra-Cellular Therapies PDE Inhibitors Quarterly Production and Revenue, 20207.14.3 Intra-Cellular Therapies PDE Inhibitors Product Introduction7.14.4 Intra-Cellular Therapies Response to COVID-19 and Related Developments7.15 Omeros Corporation7.15.1 Omeros Corporation Business Overview7.15.2 Omeros Corporation PDE Inhibitors Quarterly Production and Revenue, 20207.15.3 Omeros Corporation PDE Inhibitors Product Introduction7.15.4 Omeros Corporation Response to COVID-19 and Related Developments7.16 Medimetriks Pharmaceuticals7.16.1 Medimetriks Pharmaceuticals Business Overview7.16.2 Medimetriks Pharmaceuticals PDE Inhibitors Quarterly Production and Revenue, 20207.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Product Introduction7.16.4 Medimetriks Pharmaceuticals Response to COVID-19 and Related Developments7.17 NuSirt Biopharma7.17.1 NuSirt Biopharma Business Overview7.17.2 NuSirt Biopharma PDE Inhibitors Quarterly Production and Revenue, 20207.17.3 NuSirt Biopharma PDE Inhibitors Product Introduction7.17.4 NuSirt Biopharma Response to COVID-19 and Related Developments7.18 Palobiopharma7.18.1 Palobiopharma Business Overview7.18.2 Palobiopharma PDE Inhibitors Quarterly Production and Revenue, 20207.18.3 Palobiopharma PDE Inhibitors Product Introduction7.18.4 Palobiopharma Response to COVID-19 and Related Developments7.19 Roivant Sciences7.19.1 Roivant Sciences Business Overview7.19.2 Roivant Sciences PDE Inhibitors Quarterly Production and Revenue, 20207.19.3 Roivant Sciences PDE Inhibitors Product Introduction7.19.4 Roivant Sciences Response to COVID-19 and Related Developments7.20 Sagene Pharmaceuticals7.20.1 Sagene Pharmaceuticals Business Overview7.20.2 Sagene Pharmaceuticals PDE Inhibitors Quarterly Production and Revenue, 20207.20.3 Sagene Pharmaceuticals PDE Inhibitors Product Introduction7.20.4 Sagene Pharmaceuticals Response to COVID-19 and Related Developments7.21 Tetra Discovery Partners7.21.1 Tetra Discovery Partners Business Overview7.21.2 Tetra Discovery Partners PDE Inhibitors Quarterly Production and Revenue, 20207.21.3 Tetra Discovery Partners PDE Inhibitors Product Introduction7.21.4 Tetra Discovery Partners Response to COVID-19 and Related Developments7.22 Tritech Biopharm7.22.1 Tritech Biopharm Business Overview7.22.2 Tritech Biopharm PDE Inhibitors Quarterly Production and Revenue, 20207.22.3 Tritech Biopharm PDE Inhibitors Product Introduction7.22.4 Tritech Biopharm Response to COVID-19 and Related Developments7.23 Otsuka7.23.1 Otsuka Business Overview7.23.2 Otsuka PDE Inhibitors Quarterly Production and Revenue, 20207.23.3 Otsuka PDE Inhibitors Product Introduction7.23.4 Otsuka Response to COVID-19 and Related Developments7.24 Chiesi Farmaceutici7.24.1 Chiesi Farmaceutici Business Overview7.24.2 Chiesi Farmaceutici PDE Inhibitors Quarterly Production and Revenue, 20207.24.3 Chiesi Farmaceutici PDE Inhibitors Product Introduction7.24.4 Chiesi Farmaceutici Response to COVID-19 and Related Developments7.25 Verona Pharma7.25.1 Verona Pharma Business Overview7.25.2 Verona Pharma PDE Inhibitors Quarterly Production and Revenue, 20207.25.3 Verona Pharma PDE Inhibitors Product Introduction7.25.4 Verona Pharma Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis8.1 PDE Inhibitors Supply Chain Analysis8.1.1 PDE Inhibitors Supply Chain Analysis8.1.2 Covid-19 Impact on PDE Inhibitors Supply Chain8.2 Distribution Channels Analysis8.2.1 PDE Inhibitors Distribution Channels8.2.2 Covid-19 Impact on PDE Inhibitors Distribution Channels8.2.3 PDE Inhibitors Distributors8.3 PDE Inhibitors Customers 9 Key Findings 10 Appendix10.1 About Us10.2 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Go here to see the original:
PDE Inhibitors Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| 3w Market News Reports - 3rd Watch News

Neuroscience

Researchers Created a 3-D Map of 100 Million Cells in the Mouse Brain – Smithsonian.com

Researchers at the Allen Institute for Brain Science have accomplished a feat of cartography, creating a map of a standard mouse brain with details down to the cellular level.

The results, published on May 7 in the journal Cell, provide a 3-D atlas of an average mouses brain structure as a reference for neuroscientists everywhere. The new map is the third iteration of the project, and shows details with a new level of granularity, including over 800 brain structures and 100 million individual cells.

We hope the wider neuroscience community will use it as a new standard reference atlas, Allen Institute neuroscientist and co-author Lydia Ng tells James Lloyd at the BBCs Science Focus.

Researchers can reference the 3-D map of the mouse brain to better understand which brain regions are activated during an experiment. Different structures in the brain have certain tasks. In humans, the fusiform area can spot a face, the amygdala is the fear center, and longtime players of the Pokmon franchise may even have a region committed to recognizing the games characters. The mouse brain atlas is the based on over 1,600 mouse brains, creating a standard template that clearly delineates hundreds of structures.

Weve created this really beautiful average mouse brain, co-author David Feng told Spectrums Hannah Furfaro when the map was first presented at the Society for Neuroscience annual meeting in 2017. What you see remaining after all the averaging we do is very sharp definitions of structures that are stereotypical, which means theres not a lot of wiggle room anymore.

Neuroscientists can then use the atlas to understand where exactly theyre seeing activity in their own experiments in mice. Scientists used to eyeball the region that a blip on a measurement tool was coming from, but as modern experiments collect an increasing amount of data, a digital tool for pinpointing a signals source became vital, Ng says in a statement. Researchers can also use the average brain model to compare the shape of the brain with mice that are bred to have conditions that affect the brain.

As Ryan Blethen reported for the Seattle Times last August, researchers at the Allen Institute are also working on projects clarifying the things that our brains have in common with mouse brains, and highlighting the differences. And in October, the institute announced the completion of a map of how the mouse brain is wired. The tools are all available online for ease of access in the neuroscience field.

By making our atlas and related tools open access, new data and data types generated across our community can be more easily integrated and compared in the same spatial context, Ng tells Science Focus, and the atlas in turn can be modified as our knowledge about brain structure evolves.

Because the tool was first released online in 2017, its already been used to complete some research. University of Washington neuroscientist Nick Steinmetz used the mouse brain atlas to analyze data from a project aimed at understanding how mice choose between images. The study, published in Nature in November, used the tool to understand where exactly the brain was active.

The atlas was a really necessary resource that enabled the very idea of doing studies at the brain-wide level, Steinmetz, who wasnt involved with the new study but is associated with the Allen Institute, said in a statement. When youre recording from hundreds of sites across the brain, that introduces a new scale of investigation. You have to have a bigger view of where all the recording sites are, and the CCF [mouse brain map] is what made that possible.

Like this article?SIGN UP for our newsletter

View original post here:
Researchers Created a 3-D Map of 100 Million Cells in the Mouse Brain - Smithsonian.com

Neuroscience

DePauw graduates 472 seniors in virtual ceremony shown around the world – DePauw University

May 17, 2020

DePauw University conferred degrees today on 472 graduating seniors in a virtual ceremony streamed on YouTube.

The virtual ceremony, necessitated by the COVID-19 pandemic, will be followed by an in-person ceremony being planned for a later date. Members of the Class of 2020 voted for the dual recognitions, and DePauw wanted to ensure that degrees had been officially conferred on students whose next plans to attend graduate school or go into the military require such official action.

DePauw has a sizeable enrollment of international students, so a worldwide audience was looking on as President D. Mark McCoy told the graduates, you have done the difficult work with necessary fortitude: You have attended the classes, put in long hours of study, met with your professors and advisers and even learned how to do all of these things remotely doing anything and everything necessary to fulfill the requirements for your degrees.

You have earned the right to mark your triumphs and to celebrate your achievements.

Tim Good, the professor of communication and theatre chosen by class members to speak, said, what I have to say to you, what I am not ashamed to say, is that your teachers love you.And of course, I mean faculty, but I also mean staff members. I mean food service, laboratory assistants, administrative assistants, coaches.I meancustodians, facilities, student life and many, many others.I also mean administrators, trustees, alumni. And I really mean it. Were all here for you.

Two students were honored with the most prestigious awards DePauw gives to graduating seniors.

Brittany Davis received the Walker Cup Award, given to the member of the graduating class who has been determined to have contributed the most to the university during his or her four years of enrollment.

Upon starting my DePauw journey four years ago, I had no idea that I would be able to grow so much, both inside and outside of the classroom, said Davis, who plans to pursue an M.D.-Ph.D. program toward becoming a medical research physician. The experiences I have had have been truly incredible and have sculpted me into who I am today.

Davis, a Holton scholar from Indianapolis, double majored in neuroscience and global health and minored in Spanish and chemistry. She was a science research fellow and an information technology associate who conducted and presented several STEM research projects at major conferences; worked as a research intern for Massachusetts General Hospital for Children and Harvard Medical School; and studied and conducted research in India, Sri Lanka, South Africa, Japan and Cuba.

She was the founding member of the Students of Color in STEM organization; chartered a Minority Association of Pre-Medical Students chapter at DePauw; and worked as a mentor and a tutor in the Greencastle community as a member of Alpha Kappa Alpha Sorority Inc.

The other nominees for the Walker Cup were Luka Ignac, Summer Pappachen and Brenda Rodriguez.

Ignac, who majored in political science and French and minored in peace and conflict studies, was awarded the Murad Medal, which recognizes the senior who has had the most significant scholarly and/or artistic achievements during his or her time at DePauw.

The medal is named for Ferid Murad 58, a physician and Ph.D. pharmacologist who won the Nobel Prize for his far-reaching contributions to medical science.

Ignac, a native of Croatia, plans to attend Georgetown Universitys Master of German and European Affairs program as one of five global public service leaders to receive a prestigious McHenry Fellowship.

While a DePauw student, he investigated NATOs role in transatlantic crises, which resulted in an invitation to conduct a policy workshop during the 2019 European Conference at the Harvard Kennedy School. He served as a political affairs intern at the Embassy of the Republic of Croatia to the United States and he studied in Belgium, where he conducted comparative research on the security policies of the European Union and NATO.

He worked as an intern at DePauws Prindle Institute for Ethics, during which time he served as the president of the DePauw chapter of European Horizons, a transatlantic youth think tank based at Yale University, and coauthored several policy papers about cybersecurity, cybercrime and the consequences of Brexit for transatlantic relations.

Ignac also was selected to Phi Beta Kappa, the countrys most prestigious honor society, and Pi Sigma Alpha, the honor society for undergraduate and graduate political science students. He previously received the Richard Bunch Award for Best Junior in Political Science; the Ambassador Viron P. Vaky Award for Inter-American Relations; and the Vera Scholarship for International Students.

Other finalists for the Murad Medal were John Cotton and Zachary Wilkerson.

A video of the ceremony will be available for viewing afterward.

The rest is here:
DePauw graduates 472 seniors in virtual ceremony shown around the world - DePauw University